Remzi Bag, MD, is an expert in rare and advanced pulmonary conditions including pulmonary fibrosis, pulmonary hypertension and lung transplantation
Dr. Bag’s clinical focus has been providing leading-edge, compassionate, comprehensive care, resulting in exceptional patient outcomes. He has a particular interest in the management of patients with advanced and complex lung diseases. Dr. Bag specializes in:
- Providing direct care for lung transplant candidates and recipients
- Optimizing patients who have chronic lung failure
- Treating pulmonary hypertension and interstitial lung diseases, including idiopathic pulmonary fibrosis, Lymphangiomyomatosis and langerhans cell histiocytosis.
His interests also include:
- Improving access to lung transplantation for patients with advanced lung failure
- Educating practicing pulmonologists, pulmonary critical fellows and residents in the management of advanced lung diseases
- Optimizing outcomes for patients with chronic lung failure and transplantation.
Dr. Bag has contributed significantly to medical literature, publishing numerous peer-reviewed articles and book chapters.
Areas of Expertise
- Lymphangiomyomatosis
- Langerhans Cell Histiocytosis
- Pulmonary Fibrosis (Interstitial Lung Disease)
- Pulmonary Hypertension
Board Certifications
- Internal Medicine
- Critical Care Medicine
Memberships & Medical Societies
- American College of Physicians
- American Society of Transplantation
- United Network for Organ Sharing
- American College of Chest Physicians
- International Society for Heart and Lung Transplantation
- American Thoracic Society
Languages Spoken
- English
- Turkish
Medical Education
- GATA Gulhane Faculty of Medicine
Residency
- Montefiore Hospital; Nukleer Tip, GATA Gulhane Tip Fak; St Vincent's Hosp & Med Center
Fellowship
- Baylor College of Medicine Medical Center
News & Research
View Published Papers- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
- Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH
- Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
- DelIVery for Pulmonary Arterial Hypertension (PAH)
- Aetna HMO (specialists only)
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Aetna Better Health *see insurance page
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- Aetna Medicare Advantage HMO & PPO
- BCBS Medicare Advantage HMO & PPO
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- United Choice HMO (specialists only)
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
Request an Appointment at Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
To Refer a Patient
Refer a Patient